Neuralink has secured an impressive $600 million in a new funding round, pushing its valuation to a reported $9 billion. The funding was led by Peter Thiel’s Founders Fund and joined by other prominent investors […]
Neuralink has obtained authorization from Health Canada to start clinical trials in Canada. The company will now seek volunteers for its wireless brain implant months after starting in the US. Neuralink has brought its PRIME […]
The US Food and Drug Administration (FDA) has awarded a Breakthrough Device Designation to Neuralink’s latest brain implant device, Blindsight. This designation is given to medical devices that hold the potential to offer substantial improvements […]
Neuralink has successfully implanted a brain chip in a second patient, Elon Musk said in a newly published interview. The company aims to treat neurological disorders or enhance natural senses like vision. The ambitious company […]
Neuralink has expanded its Patient Registry beyond the borders of the US to include residents of Canada. This move broadens the scope of potential participants in Neuralink’s groundbreaking clinical trials and is a step forward […]
Elon Musk has revealed significant progress in the Neuralink project, with the first human patient now able to control a computer mouse through thought alone. Neuralink, a company co-founded by Musk, has developed a brain-computer […]
Elon Musk has announced that Neuralink has successfully implanted a brain chip into its first human subject, marking a significant stride in the realm of medical technology. This achievement, announced by Musk on the social […]
Elon Musk’s Neuralink has officially started recruitment for its first clinical trial involving humans, known as the “Precise Robotically Implanted Brain-Computer Interface study,” or PRIME study for short. This trial aims to assess the capabilities […]
Neuralink will hopefully start its first human trials later this year, according to CEO Elon Musk who revealed the timeline at the VivaTech event in Paris. Last month the company received clearance from the Food […]
Neuralink has announced it received approval from the Food and Drug Administration (FDA) to launch a clinical study of its brain-computer interface (BCI) involving humans. Neuralink was founded by CEO Elon Musk in 2016, and […]
